Premium
Generic Equivalents: Issues and Concerns
Author(s) -
Lamy Peter P.
Publication year - 1986
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1986.tb03531.x
Subject(s) - bioequivalence , identification (biology) , medicine , engineering ethics , management science , risk analysis (engineering) , psychology , pharmacology , pharmacokinetics , engineering , biology , botany
Critical questions remain concerning many issues involved in the identification of bioequivalent and therapeutically equivalent drugs. They need to be answered, and scientists and clinicians should address these issues, in concert with the FDA, as soon as possible.